Drug repurposing is attracting growing attention as a strategy to address unmet medical needs by identifying new uses for existing medicines. Against this backdrop, the Reagan-Udall Foundation for the FDA,…
Jake Fairnie12 August 2026
The growing popularity of drug repurposing as a viable alternative to drug development to secure patient access to treatments has garnered media attention, with international news outlets reporting on repurposing initiatives including The REMEDi4ALL project. Below we have collated the most relevant articles where REMEDi4ALL has been mentioned by the press.
REMEDi4ALL and iDR26 features in a RARE Revolution insider piece on “Drug repurposing: translating optimism into action for rare diseases” highlighting discussions at the conference and outlining ongoing hurdles related to realising the full potential of drug repurposing.
tools@teamitresearch.com29 July 2026
Prof. Zoltán Kaló, co-founder of REMEDi4ALL partner organisation Syreon Research Institute, has been appointed Director General of Hungary’s National Health Insurance Fund, taking up a senior leadership position within the newly formed Hungarian Government. Prof….
tools@teamitresearch.com10 July 2026
REMEDi4ALL and iDR26 features in a RARE Revolution insider piece on “Drug repurposing: translating optimism into action for rare diseases” highlighting discussions at the conference and outlining ongoing hurdles related to realising the full potential of drug repurposing.
tools@teamitresearch.com18 June 2026
REMEDi4ALL features in a Reader’s Digest piece on “How AI is saving lives: Artificial intelligence can find new uses for existing drugs, helping to treat rare diseases, including the one that almost killed Joseph Coates” with an interview from REMEDi4ALL Scientific Coordinator Donald Lo.
tools@teamitresearch.com10 April 2026
This Forbes article highlights iDR25 (the International Drug Repurposing Conference) and the growing potential of drug repurposing to expand treatment possibilities in rare diseases.
Piret Baur2 September 2025
REMEDi4ALL features in an article republished in The Age (Melbourne, Australia) on the power of AI in drug repurposing with an interview from REMEDi4ALL Scientific Coordinator Donald Lo.
Jeroen7 April 2025
El País covers highlights the promise of Drug Repurposing and the REMEDi4ALL project (French translation).
Jeroen7 April 2025
El País covers highlights the promise of Drug Repurposing and the REMEDi4ALL project (Spanish version).
Jeroen7 April 2025
REMEDi4ALL features in a New York Times article on the power of AI in drug repurposing with an interview from REMEDi4ALL Scientific Coordinator Donald Lo.
Jeroen4 April 2025
REMEDi4ALL partner Beacon for Rare Diseases featured in Mediaplanet’s Rare Disease Day campaign – both online and in print.
In the piece, Beacon CEO Rick Thompson highlighted the power of multistakeholder collaborations like REMEDi4ALL, in accelerating the delivery of much-needed treatments to rare disease patients.
Jeroen4 April 2025
El País covers highlights the promise of Drug Repurposing and the REMEDi4ALL project (English version).
Jeroen4 April 2025
“La Nuova Era del drug repurposing” (Notiziario Chimico Farmaceutico – July 2026)
“La Nuova Era del drug repurposing” (Notiziario Chimico Farmaceutico – July 2026)
“Drug repurposing: translating optimism into action for rare diseases” (RARE Revolution insider – June 2026)
“Drug repurposing: translating optimism into action for rare diseases” (RARE Revolution insider – June 2026)
“How AI is saving lives” (Reader’s Digest – April/May 2026)
“How AI is saving lives” (Reader’s Digest – April/May 2026)
“Doctors told him he was going to die. Then A.I. Saved his life.” (New York Times – March 2025)
“Doctors told him he was going to die. Then A.I. Saved his life.” (New York Times – March 2025)
REMEDi4ALL Partners & Associated partners
